VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SONN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SONNSonnet BioTherapeutics Holdings, Inc.
$1.26$9M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSONNPrice History

SONN logoSonnet BioTherapeutics Holdings, Inc. (SONN) Stock Price History

Historical prices from 2006 to 2025

$1.26+0.00  (+0.00%)close Dec 3
Returns
1M
—
3M
—
YTD
—
1Y
+9.6%
3Y
-78.2%
5Y
-82.4%
ATH$999,999.00Dec 2016-100.0%
ATL$1.08May 2025pre-split
Avg Vol (50D)10.4M/ day
52-Week Range$1.11 — $19.30
LowCurrent: $1.26High

Loading 10-year price history...

SONN Historical Performance

1 YearTotal Return
+9.6%
Price: +9.6%
3 YearsTotal Return
-99.0%
CAGR: -78.2%
Price: -99.0%
5 YearsTotal Return
-100.0%
CAGR: -82.4%
Price: -100.0%
YTD
-

SONN Annual Returns

Year-by-year price performance · 2006–2025

Best+0.0%2015
Worst-93.2%2023
Up years10/20
2006+0.0%
2007+0.0%
2008+0.0%
2009+0.0%
2010+0.0%
2011+0.0%
2012+0.0%
2013+0.0%
2014+0.0%
2015+0.0%
2016-46.2%
2017-37.5%
2018-65.3%
2019-56.3%
2020-85.2%
2021-91.0%
2022-81.2%
2023-93.2%
2024-89.6%
2025-21.3%
2006 annual price return
+0.0%
2007 annual price return
+0.0%
2008 annual price return
+0.0%
2009 annual price return
+0.0%
2010 annual price return
+0.0%
2011 annual price return
+0.0%
2012 annual price return
+0.0%
2013 annual price return
+0.0%
2014 annual price return
+0.0%
2015 annual price return
+0.0%
2016 annual price return
-46.2%
2017 annual price return
-37.5%
2018 annual price return
-65.3%
2019 annual price return
-56.3%
2020 annual price return
-85.2%
2021 annual price return
-91.0%
2022 annual price return
-81.2%
2023 annual price return
-93.2%
2024 annual price return
-89.6%
2025 annual price return
-21.3%
LessMore
Alpha vs S&P 500
1Y-11.3%
3Y-97.8%
5Y-94.0%

Price returns only.

Download Historical Data

4,802 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SONN Stock Price Trajectory (2006–2026)

As of June 29, 2026, Sonnet BioTherapeutics Holdings, Inc. (SONN) trades at $1.26, representing a +9.6% return over the past year. The stock has delivered a -100.0% total return over five years (-82.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $999,999.00 on December 8, 2016. From this peak, SONN has corrected -100.0%, currently trading 58% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ALDX (-52.7% 1Y), CRVS (+220.4% 1Y), and IMMP (-76.0% 1Y), SONN has underperformed the peer group average. Compare SONN vs ALDX →

SONN Historical Price Data · from 2006

Rows 1–50 of 4,802
Date Open High Low Close Volume Change %
2025-12-033.163.231.261.2610.43M0.00%
2025-12-023.163.231.261.268.69M-59.35%
2025-12-013.833.923.103.10911K-16.67%
2025-11-284.154.253.663.72418K-10.58%
2025-11-264.214.243.564.161.38M0.00%
2025-11-254.704.964.134.16662K-14.23%
2025-11-244.465.064.404.85584K+6.59%
2025-11-214.284.583.954.55637K+3.17%
2025-11-204.604.694.124.41614K-2.22%
2025-11-194.985.074.204.51645K-7.77%
2025-11-185.175.454.664.89763K-8.60%
2025-11-175.805.954.755.35874K-9.63%
2025-11-144.435.954.055.921.59M+9.63%
2025-11-134.625.444.425.401.05M+13.45%
2025-11-124.544.824.304.76516K+3.48%
2025-11-114.364.643.724.60516K+3.14%
2025-11-105.045.144.414.46538K-8.42%
2025-11-074.104.984.064.87796K+15.40%
2025-11-064.404.664.024.22541K-7.25%
2025-11-053.504.723.214.551.48M+42.19%
2025-11-044.044.073.123.20922K-20.60%
2025-11-034.854.993.994.03612K-19.72%
2025-10-314.875.164.685.02519K+6.81%
2025-10-304.735.004.534.70432K-1.05%
2025-10-294.895.054.424.75822K-2.86%
2025-10-285.645.814.854.89612K-16.41%
2025-10-275.215.855.035.851.06M+18.42%
2025-10-244.505.354.484.94737K+11.26%
2025-10-233.804.533.724.44800K+22.31%
2025-10-223.813.883.523.63240K-6.68%
2025-10-214.124.193.893.89231K-2.99%
2025-10-203.734.093.644.01324K+10.47%
2025-10-173.733.793.483.63216K-2.68%
2025-10-164.104.153.623.73405K-5.57%
2025-10-154.424.463.873.95461K-8.35%
2025-10-144.204.504.184.31400K-1.37%
2025-10-134.504.534.214.37343K-0.91%
2025-10-104.744.994.334.41549K-6.96%
2025-10-094.945.054.714.74302K-7.60%
2025-10-085.055.194.825.13328K+1.58%
2025-10-075.395.554.905.05576K-7.17%
2025-10-065.636.105.425.44385K-3.37%
2025-10-036.106.195.335.63531K-6.32%
2025-10-025.216.055.056.01767K+19.48%
2025-10-014.615.584.615.03700K+9.83%
2025-09-304.854.914.254.58621K-6.34%
2025-09-295.085.294.854.89667K-8.26%
2025-09-265.335.594.925.33604K0.00%
2025-09-255.965.994.825.331.12M-14.17%
2025-09-245.916.385.916.21475K+4.19%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SONN — Frequently Asked Questions

Quick answers to the most common questions about buying SONN stock.

How has SONN stock performed recently?

SONN returned +9.6% over the past year, beating its 5-year annualized CAGR of -82.4%. The stock trades below its 200-day moving average, confirming the uptrend.

What is SONN's all-time high price?

Sonnet BioTherapeutics Holdings, Inc. reached $999999.00 on 2016-12-08. The 52-week high is $19.30. Current 1-year return of +9.6% places the stock closer to historical peaks.

Where can I download SONN historical price data?

This page provides SONN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2006-2025, downloadable in CSV format.

482 data points · sampled from 4,802